Prudential Financial’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $34.8M | Sell |
|
|||||
|
2021
Q1 | $30.4M | Sell |
|
|||||
|
2020
Q4 | $58.3M | Buy |
|
|||||
|
2020
Q3 | $39.4M | Buy |
|
|||||
|
2020
Q2 | $32.9M | Sell |
|
|||||
|
2020
Q1 | $35M | Sell |
|
|||||
|
2019
Q4 | $72.3M | Sell |
|
|||||
|
2019
Q3 | $66M | Sell |
|
|||||
|
2019
Q2 | $155M | Buy |
|
|||||
|
2019
Q1 | $85.6M | Buy |
|
|||||
|
2018
Q4 | $42.1M | Buy |
|
|||||
|
2018
Q3 | $43.7M | Sell |
|
|||||
|
2018
Q2 | $44.1M | Buy |
|
|||||
|
2018
Q1 | $30M | Sell |
|
|||||
|
2017
Q4 | $51.8M | Buy |
|
|||||
|
2017
Q3 | $54.5M | Buy |
|
|||||
|
2017
Q2 | $47.1M | Buy |
|
|||||
|
2017
Q1 | $37.6M | Buy |
|
|||||
|
2016
Q4 | $37.6M | Sell |
|
|||||
|
2016
Q3 | $38.1M | Sell |
|
|||||
|
2016
Q2 | $44M | Buy |
|
|||||
|
2016
Q1 | $48.1M | Buy |
|
|||||
|
2015
Q4 | $64.1M | Buy |
|
|||||
|
2015
Q3 | $52.5M | Buy |
|
|||||
|
2015
Q2 | $54.6M | Sell |
|
|||||
|
2015
Q1 | $123M | Sell |
|
|||||
|
2014
Q4 | $157M | Sell |
|
|||||
|
2014
Q3 | $142M | Buy |
|
|||||
|
2014
Q2 | $124M | Buy |
|
|||||
|
2014
Q1 | $116M | Buy |
|
|||||
|
2013
Q4 | $86.9M | Sell |
|
|||||
|
2013
Q3 | $81.4M | Buy |
|
|||||
|
2013
Q2 | $60M | Buy |
|